Ushio (6925) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
9 Sep, 2026Executive summary
FY2025 saw higher revenue and earnings, both exceeding plan, driven by recovering demand for imaging equipment and improved profitability from business portfolio revamp.
Net sales rose 0.9% year-over-year to ¥179,211 million, with operating profit up 35.5% to ¥11,959 million and profit attributable to owners of parent increased 17.6% to ¥7,995 million.
Comprehensive income surged to ¥23,524 million from a loss of ¥2,764 million the previous year.
Forward investments in lithography equipment and DLT systems expanded as planned, despite delayed earnings from advanced packaging.
The acquisition of the OSRAM lamp business was completed, with consolidation starting and earnings contribution expected from FY2027 onward.
Financial highlights
FY2025 net sales: ¥179.2 billion (+0.9% YoY); operating profit: ¥11.9 billion (+35.5% YoY); profit attributable to owners: ¥7.9 billion (+17.6% YoY).
Gross profit increased to ¥65,518 million from ¥62,215 million year-over-year.
Operating margin improved to 6.7% (+1.7pts YoY); EPS rose to ¥94.88 (+35.0% YoY); ROE reached 4.0% (adjusted 4.6%).
Cash and cash equivalents at year-end were ¥71,868 million, up ¥11,872 million from the previous year.
Extraordinary income: ¥10.0 billion gain on sale of investment securities; extraordinary losses: ¥6.3 billion restructuring, ¥1.3 billion impairment.
Outlook and guidance
FY2026 forecasts: net sales ¥210.0 billion (+17.2% YoY), operating profit ¥14.0 billion (+17.1% YoY), profit attributable to owners ¥10.5 billion (+31.3% YoY), ROE 5.2%.
Growth driven by semiconductor-related light sources, lithography equipment, and OSRAM business consolidation.
Growth is expected in Industrial Processes and Visual Imaging, with Life Sciences and Photonics Solutions projected to remain flat in profit.
Dividend maintained at ¥70/share; share buybacks to continue flexibly.
Latest events from Ushio
- Profits and sales fell sharply, but guidance and dividend forecasts remain unchanged.6925
Q1 2025 - Net sales grew 0.8% but profits fell sharply; full-year profit outlook revised upward.6925
Q2 2025 - Profits and sales fell but exceeded forecasts; dividend and buybacks increased.6925
Q3 2025 - Operating profit dropped 32% on lower sales and inventory write-downs, but cash flow improved.6925
Q4 2025 - Net loss despite higher sales, with lamp business acquisition to support future growth.6925
Q1 2026 - Profits and sales declined YoY, but cash flow and select segment earnings improved.6925
Q2 2026 - Operating profit rose despite lower sales, with strong gains in Visual Imaging and Life Sciences.6925
Q3 2026